Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06571812 · ClinicalTrials.gov registry record
A Clinical Study of the TSX Dental Implant System (Xpresso)
A clinical trial of Tooth Loss, sponsored by ZimVie.
- Recruiting
- Registry status
- 62
- Enrollment target
- 2
- Study locations
NCT06571812: Recruiting study of Tooth Loss, sponsored by ZimVie.
NCT06571812 is a study of Tooth Loss that is actively recruiting participants, run by ZimVie. The registered enrollment target is 62 participants, below the 98-participant average among 11 other Tooth Loss trials with a reported enrollment target (37% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06571812, a study of Tooth Loss, is actively recruiting participants, sponsored by ZimVie.
- RECRUITING
- Registry status
- 62 participants
- Enrollment target
- 2
- Study locations
Study Summary
A prospective, observational, multicenter study where 62 patients needing implants in the maxilla or mandible will be enrolled. The patients will be restored with a final prosthesis no later than 4 months following implant placement surgery. The patients will come back for follow-up evaluations yearly for 2 years.
Primary Outcome
Integration success (survival) of the implant will be determined by lack of mobility, no declared pain, absence of radiolucency, absence of infection and reaching primary stability upon final placement of implant until 2 years later.
Conditions Studied
Interventions
- DEVICE TSX
Study Locations (2)
Ohio
- Ohio State University - Columbus
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2024-04-24 |
| Est. Completion | 2027-06 |
What NCT06571812 shows while recruiting
NCT06571812 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 98-participant average among 11 other Tooth Loss trials with a reported enrollment target (37% lower).
The record links to 1 condition, with Tooth Loss appearing as the primary indexed condition, and to 1 intervention - of which TSX is the first listed.
NCT06571812 reports a single indexed study location in Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06571812 about?
NCT06571812 is a clinical study titled "A Clinical Study of the TSX Dental Implant System (Xpresso)". A prospective, observational, multicenter study where 62 patients needing implants in the maxilla or mandible will be enrolled. The patients will be restored with a final prosthesis no later than 4 months following implant placement surgery. The patients will come back for follow-up evaluations year...
What is the current status of trial NCT06571812?
This trial is currently recruiting. The enrollment target is 62 participants. The study started on 2024-04-24. Estimated completion is 2027-06.
What conditions does trial NCT06571812 study?
This clinical trial studies the following conditions: Tooth Loss.
What interventions are being tested in trial NCT06571812?
The interventions under investigation include: TSX (DEVICE).
Who is sponsoring clinical trial NCT06571812?
This trial is sponsored by ZimVie, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06571812 being conducted?
This trial has 2 study locations across Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tooth Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06571812's enrollment target sits among peer trials
62 3rd of 11 higher than 9 of 11 other Tooth Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tooth Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Peri-implant Mucosal Changes Over Time Following Implant Provisional Removal in the Esthetic Zone
RECRUITING
-
5-Years PMCF Study of Ceramic Dental Implants One-piece Versus Two-piece.
RECRUITING
-
An Observational Study of the T3 Pro Dental Implant System
RECRUITING
-
Clinical Performance of Nobel N1 System
RECRUITING · Phase 4
-
Bone Level Tapered Multi-Center Study
ACTIVE NOT RECRUITING · NA
-
Comparison of Dimensional Changes After Tooth Extractions Between Xenograft and Allograft
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI